InVivo Therapeutics Corporation Announces Barnes-Jewish Hospital At InVivo Therapeutics Corporation As New Clinical Trial Site For Neuro-Spinal Scaffold
CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today announced that the Barnes-Jewish Hospital at Washington University Medical Center in St. Louis, MO, is the fourth clinical site in the company’s on-going IDE pilot study of its Neuro-Spinal Scaffold in patients with acute spinal cord injury (SCI). Barnes-Jewish Hospital is the largest regional trauma center in St. Louis and is one of the largest clinical spine care practices for the United States. Paul Santiago, MD, an Associate Professor of Neurological Surgery and Orthopedic Surgery at the Washington University School of Medicine in St. Louis, will be the study’s Principal Investigator at the Barnes-Jewish Hospital.
Dr. Santiago said, “We look forward to participating in the evaluation of this novel treatment for acute spinal cord injury and hope that it we will be able to advance the treatment of patients with spinal cord injuries.”
Help employers find you! Check out all the jobs and post your resume.
Dr. Santiago said, “We look forward to participating in the evaluation of this novel treatment for acute spinal cord injury and hope that it we will be able to advance the treatment of patients with spinal cord injuries.”
Help employers find you! Check out all the jobs and post your resume.